Clinical Trials
101 trialsSafety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Zhujiang Hospital
HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer
Shanghai Huilun Pharmaceutical Co., Ltd.
Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children
Biotech Pharmaceutical Co., Ltd.
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Fudan University
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
Peking Union Medical College Hospital
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
Emory University
The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma
Fudan University
RE-GEND
Kyorin University
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
University of Louisville
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Beijing Tiantan Hospital
A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
Taizhou Hanzhong biomedical co. LTD
Irinotecan and Temozolomide for Ewing Sarcoma
Peking University People's Hospital
A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
Sun Yat-sen University
ERASE-TMZ
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
HIT-HGG-2013
University of Göttingen
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Sun Yat-sen University
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
Massachusetts General Hospital
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
ChineseAMS
TEMOTRAD01
Assistance Publique - Hôpitaux de Paris
A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
First Affiliated Hospital of Zhejiang University
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Johnpro Biotech, Inc.
Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
Peking Union Medical College Hospital
HUTMZ
Amsterdam UMC, location VUmc
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Shandong Cancer Hospital and Institute
HSCK-010
Huashan Hospital
AEO
MetVital, Inc.
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma
Peking University Cancer Hospital & Institute
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
Fuzhou General Hospital
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Northwestern University
The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas
Peking Union Medical College Hospital
RACTAC
Regina Elena Cancer Institute
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
People's Hospital of Guangxi Zhuang Autonomous Region
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
The Second Hospital of Hebei Medical University
HFSRT With Concurrent TMZ for Large BMs
ChineseAMS
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
Leaf Vertical Inc.
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
Huashan Hospital
Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases
Taizhou Hospital
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
NovoCure Ltd.
Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
Mashhad University of Medical Sciences
Gut Microbiota and Glioblastoma Multiforme Prognosis
Huashan Hospital
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.